FACTSHEETS ON LASSA FEVER

FACTSHEETS ON LASSA FEVER

Last week, Nigerians got a rude shock. Lassa Fever Epidemic is with us again. About ten states in the Federation has reported cases total of about 91 with mortality of roughly 40%. This necessitates this fact sheet on the disease for doctors, other health workers, and everyone.

We reproduce it here because of its importance and because everyone in Nigeria and other parts of the world would benefit from it regardless of whether one is a health worker or not.

 

EPIDEMIOLOGY

Lassa Fever is an Acute Febrile disease caused by the Lassa virus belonging to the arenavirus group. It was first described in the 50s and the virus was isolated in 1969 in Lassa, Nigeria. Lassa Fever occurs more often in the dry season, rather than in the rainy season. The multimammate rat (Mastomys natalensis) is the reservoir host of Lassa fever. Deafness is a common sequela, up to 1/3 cases. Case fatality rate varies from as low as 1%-25% to as high as 50%. The death rates are particularly high for women in the third trimester of pregnancy, and for fetuses, about 95% of which die in the uterus of infected pregnant mothers.

Cases have been reported in some states in Nigeria in January 2016 which includes Bauchi, Kano, Nassarawa, Niger, Rivers, Edo, Lagos, and Taraba.

TRANSMISSION 
Humans usually become infected with Lassa virus from exposure to excreta of infected Mastomys via direct exposure (to the excreta) of rat. Lassa virus may also be spread between humans through direct contact with the blood, urine, faeces, or other bodily secretions of a person with Lassa Fever. There is no epidemiological evidence supporting airborne spread between humans. Person-to-person transmission occurs in both community and health care settings, where the virus may be spread by contaminated medical equipment, such as re-used needles. Sexual transmission of Lassa virus has been reported.
Incubation Period is usually about 10 days but can range from 6-21 days.

 

Case Definition:

a) Suspected case- Illnesses with onset of Fever, with or without sore throat and at least one of the following signs: bloody diarrhea, bleeding from gums, bleeding into skin (purpura), bleeding into eyes and urine.
b) Confirmed case- A suspected case with laboratory confirmation (positive IgM antibody or viral isolation) or epidemiological link to confirm cases or outbreaks.

Clinical Presentation

1. Mild onset over days:
– Fever, malaise, headache, myalgia, arthralgia, prostration
2. Gastrointestinal symptoms common
– Anorexia, nausea, vomiting, diarrhea, abdominal pain
3. Cough, dyspnea, chest pain may be seen
– Pulmonary edema after IV fluids
4. Central nervous system may be involved in late stages
– Agitation, confusion, tremor to coma and convulsions
5. Hemorrhage
– Gastrointestinal, conjunctival injection/sub-conjunctival hemorrhage
6. “Classic” presentation: fever, neck/facial swelling, bleeding (petechial hemorrhage) and shock (but not typical)
• Patients die from combination of increased capillary permeability, cardiac suppression and coagulopathy leading to a low effective circulating volume leading to shock, NOT loss of blood
• Common laboratory findings:
– Early leukopenia, late leukocytosis
– Mild-to-moderate thrombocytopenia
– Elevated hepatic transaminases (AST>ALT)

Laboratory Confirmation

Lassa virus infections can only be diagnosed definitively in the laboratory using the following tests:
• Antibody enzyme-linked immunosorbent assay (ELISA)
• Antigen detection tests
• Reverse transcriptase polymerase chain reaction (RT-PCR) assay
• Virus isolation by cell culture.

This test can be done at Virology Reference Laboratory at Lagos University Teaching Hospital, Idi-Araba, Lagos.

Management.

The only known specific treatment for Lassa Fever is Ribavirin and may be effective if given within the first six days of illness. It should be given intravenously for ten (10) days.

 

1) Intravenous Ribavirin treatment should start as soon as a diagnosis of Lassa Fever is made.
2) Give a single “loading dose” of 33mg per Kg body weight.
3) Then give a dose of 16mg/ Kg body weight every 6 hours for 4 days.
4) Then give 8mg/Kg every 8 hours for 6 days.
5) Complete treatment course for individual patient clearly laying out the correct amount to give each dose.
6) Once started, a Ribavirin treatment should not be discontinued until the 10 days course is complete.
7) Supportive treatment should include; Paracetamol, Vitamin K (Phytamenadione), Heamacel, Ringers lactate, Quinine lactate, Quinine injection, and antibiotics- start by I.V.
8) If patient is severely anaemic, consider transfusion.

Prophylaxis

Tablets:  Adults 500mg every 6 hours X 5 days
Children > 5 years: 500mg every 12 hours X 5 days

Adverse Effects of Ribavirin

Major side-effect is a reversible, most-often mild anemia. Women who are pregnant or planning to become pregnant are advised not to take Ribavirin

Prevention of Lassa Fever

High Index of suspicion for Lassa Fever should be entertained by health workers to improve case detection. UNIVERSAL PRECAUTION must be practiced in the management of suspected or confirmed cases as listed below:

1. Appropriate personal protective clothings (hand gloves, facemasks, eye goggles and overall) must be worn when attending to cases.

2. Hands must be washed after each contact with patient or contaminated materials. They must first be rinsed in disinfectant and then washed with soap and water.

3. Instruments and Dressings – Each patient must have an individual thermometer labelled with the patient’s name and kept in a receptacle containing disinfectant. The stethoscope and the sleeve of the syphgmomanometre must be decontaminated between each use by rinsing them in disinfectant solution.

4. Bed covering – The use of a plastic sheet is essential to avoid the contamination of mattresses. They must be large enough to cover the entire mattress, be waterproof, and be thoroughly disinfected after the discharge or the death of patients.

 

FOR THOSE IN LAGOS

In case of any suspected case of Lassa Fever, Lagos State Ministry of Health should be notified by calling these GSM numbers: 08022234273, 08037170614 and 08023169485.

Any suspected case should be taken to Mainland Hospital, Yaba.

 

IN OTHER PARTS OF THE COUNTRY

Health workers seeing a patient suspected to have Lassa fever should immediately contact the state ministry of health or call FMH on these numbers:

08093810105

08163215251

08031571667 &

08135050005.

The Nigerian Centre for Disease Control NCDC is already coordinating responses and reporting to the Health Minister on daily basis.

Referral
The Medical Officer of Health at Primary HealthCare Centres (PHCs) or Private Clinics and Hospitals with any determined Suspected Case seen should notify the Medical Director of the nearest General Hospital for immediate transfer to the General Hospital.

NOTE: ALL ITEMS WITH POSSIBLE CONTACT WITH ANY CASE MUST BE THOROUGHLY DISINFECTED BEFORE REPEATED USE.

Dear reader, please feel free to share, forward, edit, or copy this write-up and broadcast as much as you can so that more people will be aware of this deadly disease and take nessesary precautions.

Share

Article written by

The Admin is a medical doctor with practice in the tropics. An infotech enthusiast, a scientist, and a smartphone geek. Follow him on twitter @deolaonline

One Response

  1. Afewgoodmen
    Afewgoodmen at | | Reply

    Quite a detailed article. It’s a shame that this Lassa epidemic isn’t getting as much traction as Ebola.

    But I believe your article is a clarion for all doctors practising in the country and other health workers to be vigilant. Prevention is the way to go. Always preferable to a cure.

Please comment with your real name using good manners.

Leave a Reply